Successful treatment of a patient with adult T-cell leukemia by daily oral administration of low-dose etoposide. Decrease in the amount of HTLV-I proviral DNA revealed by the polymerase chain reaction method

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

1980 • 5,022 citations

Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide

1987 • 1,175 citations

DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.

1983 • 223 citations

Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.

1985 • 188 citations

Chronic daily administration of oral etoposide--a phase I trial.

1989 • 153 citations

Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia.

1983 • 143 citations

Major prognostic factors of patients with adult T-cell leukemia-lymphoma: A cooperative study

1991 • 115 citations

Chronic daily administration of oral etoposide in refractory lymphoma

1990 • 83 citations

Infection of rats with HTLV‐1: A small‐animal model for HTLV‐1 carriers

1991 • 50 citations

Final Results of Cooperative Study of VEPA [Vincristine, Cyclophosphamide (Endoxan), Prednisolone and Adriamycin] Therapy in Advanced Adult Non-Hodgkin's Lymphoma: Relation Between T- or B-Cell Phenotype and Response

1982 • 49 citations

Etoposide as a single agent in relapsed advanced lymphomas

1982 • 46 citations

Issues for the future development of fludarabine phosphate.

1990 • 32 citations

A Simple and Reliable Method for the Detection and Quantitation of the Human T-cell Leukemia Virus Type-I Provirus in Peripheral Blood Mononuclear Cells of Seropositive Blood Donors

1992 • 5 citations